These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11558152)

  • 1. [U.S. warns on some use of anti-AIDS drug].
    Hayashi T
    Yakugaku Zasshi; 2001 Sep; 121(9):679-82. PubMed ID: 11558152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New therapy reduces AIDS passed to fetuses and costs less].
    Hayashi T
    Yakugaku Zasshi; 2000 Aug; 120(8):683-7. PubMed ID: 10946618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jan; 49(51-52):1153-6. PubMed ID: 11198946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of mother-to-child transmission with single dose nevirapine and human immunodeficiency virus drug resistance].
    Han JF; Jiang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):730-3. PubMed ID: 19031772
    [No Abstract]   [Full Text] [Related]  

  • 6. Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals.
    Patel SM; Johnson S; Belknap SM; Chan J; Sha BE; Bennett C
    J Acquir Immune Defic Syndr; 2004 Feb; 35(2):120-5. PubMed ID: 14722442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316.
    Cunningham CK; Chaix ML; Rekacewicz C; Britto P; Rouzioux C; Gelber RD; Dorenbaum A; Delfraissy JF; Bazin B; Mofenson L; Sullivan JL
    J Infect Dis; 2002 Jul; 186(2):181-8. PubMed ID: 12134253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.
    Giaquinto C; Rampon O; De Rossi A
    Clin Drug Investig; 2006; 26(11):611-27. PubMed ID: 17163296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe leukopenia associated with mild hepatotoxicity in an HIV carrier treated with nevirapine.
    Shahar E; Krivoy N; Weltfriend S; Pollack S
    Jpn J Infect Dis; 2004 Oct; 57(5):212-3. PubMed ID: 15507779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inexpensive AIDS drug still reduces HIV transmission from mother to child after 1 year.
    AIDS Read; 2000 Sep; 10(9):522. PubMed ID: 11019439
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
    Sha BE; Proia LA; Kessler HA
    JAMA; 2000 Dec; 284(21):2723. PubMed ID: 11105176
    [No Abstract]   [Full Text] [Related]  

  • 14. Rash, hepatotoxicity and hyperbilirubinemia among Kenyan infants born to HIV-infected women receiving triple-antiretroviral drugs for the prevention of mother-to-child HIV transmission.
    Minniear TD; Zeh C; Polle N; Masaba R; Peters PJ; Oyaro B; Akoth B; Ndivo R; Angira F; Mills LA; Thomas TK
    Pediatr Infect Dis J; 2012 Nov; 31(11):1155-7. PubMed ID: 22772167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the Centers for Disease Control and Prevention. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
    JAMA; 2001 Jan 24-31; 285(4):402-3. PubMed ID: 11263401
    [No Abstract]   [Full Text] [Related]  

  • 16. Activists angry at fallout from AIDS drug trial allegations.
    Check E
    Nat Med; 2005 Mar; 11(3):238. PubMed ID: 15746922
    [No Abstract]   [Full Text] [Related]  

  • 17. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.
    Bardsley-Elliot A; Perry CM
    Paediatr Drugs; 2000; 2(5):373-407. PubMed ID: 11022799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N; Poolsup N; Ket-Aim S
    J Clin Pharm Ther; 2007 Jun; 32(3):293-311. PubMed ID: 17489882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Ann N Y Acad Sci; 2000 Nov; 918():53-6. PubMed ID: 11131734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.